Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 1/20 | 0.56 |
| ▸ | CA1 | P00915 | 1/20 | 0.56 |
| ▸ | CA2 | P00918 | 1/20 | 0.56 |
| ▸ | CA9 | Q16790 | 1/20 | 0.56 |
| ▸ | MGAM | O43451 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | SI | P14410 | 1/20 | 0.41 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.41 |
| ▸ | GSTO1 | P78417 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.41 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.39 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20125897 | 0.85 | CA12 (0.41) | CA12CA1CA2CA9GSTO1 | |
| SCHEMBL16281562 | 0.82 | CA12 (0.44) | CA12CA1CA2CA9MGAM | |
| SCHEMBL20125898 | 0.82 | TSHR (0.53) | CA12CA1CA2CA9ALDH1A1 | |
| SCHEMBL20125964 | 0.81 | CA12 (0.41) | CA12CA1CA2CA9MGAM | |
| SCHEMBL20125936 | 0.80 | TSHR (0.52) | CA12CA1CA2CA9ALDH1A1 | |
| SCHEMBL517265 | 0.80 | GSTO1 (0.39) | CA12CA1CA2CA9MGAM | |
| SCHEMBL23420608 | 0.80 | NAAA (0.51) | ALDH1A1HPGDTSHR | |
| SCHEMBL20125937 | 0.80 | NAAA (0.51) | ALDH1A1HPGDTSHR | |
| SCHEMBL13411271 | 0.79 | CA12 (0.42) | CA12CA1CA2CA9MGAM | |
| SCHEMBL20126074 | 0.79 | CYP1A2 (0.46) | CA12CA1CA2CA9MGAM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12286491-B2 | Image forming device and image forming method | RICOH COMPANY, LTD. (JP) | 2025-04-29 | — | — | US | disclosed |
| CN-112469306-B | Composition, artificial nail composition, nail decorating material, artificial nail, storage container, image forming apparatus, and image forming method | 株式会社理光 | 2024-07-05 | — | — | CN | disclosed |
| US-12023398-B2 | Composition, artificial nail composition, nail decoration material, artificial nail, stored container, image forming apparatus, and image forming method | RICOH COMPANY, LTD. (JP) | 2024-07-02 | — | — | US | disclosed |
| WO-2023215559-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS | ARIA PHARMACEUTICALS, INC. (US) | 2023-11-09 | — | — | WO | disclosed |
| US-20230135413-A1 | CURABLE WATER-BASED COMPOSITION, ACTIVE-ENERGY-RAY-CURABLE WATER-BASED COMPOSITION, ACTIVE-ENERGY-RAY-CURABLE WATER-BASED INK, STORED CONTAINER, TWO-DIMENSIONAL OR THREE-DIMENSIONAL IMAGE FORMING APPARATUS, TWO-DIMENSIONAL OR THREE-DIMENSIONAL IMAGE FORMING METHOD, CURED PRODUCT, AND DECORATED BODY | RICOH COMPANY, LTD. (JP) | 2023-05-04 | — | — | US | disclosed |
| US-20230135413-A1 | CURABLE WATER-BASED COMPOSITION, ACTIVE-ENERGY-RAY-CURABLE WATER-BASED COMPOSITION, ACTIVE-ENERGY-RAY-CURABLE WATER-BASED INK, STORED CONTAINER, TWO-DIMENSIONAL OR THREE-DIMENSIONAL IMAGE FORMING APPARATUS, TWO-DIMENSIONAL OR THREE-DIMENSIONAL IMAGE FORMING METHOD, CURED PRODUCT, AND DECORATED BODY | RICOH COMPANY, LTD. (JP) | 2023-05-04 | — | — | US | disclosed |
| US-20230135413-A1 | CURABLE WATER-BASED COMPOSITION, ACTIVE-ENERGY-RAY-CURABLE WATER-BASED COMPOSITION, ACTIVE-ENERGY-RAY-CURABLE WATER-BASED INK, STORED CONTAINER, TWO-DIMENSIONAL OR THREE-DIMENSIONAL IMAGE FORMING APPARATUS, TWO-DIMENSIONAL OR THREE-DIMENSIONAL IMAGE FORMING METHOD, CURED PRODUCT, AND DECORATED BODY | RICOH COMPANY, LTD. (JP) | 2023-05-04 | — | — | US | disclosed |
| US-20230077371-A1 | CURABLE COMPOSITION, CURABLE INK, COMPOSITION CONTAINER, DEVICE FOR FORMING TWO-DIMENSIONAL OR THREE-DIMENSIONAL IMAGE, METHOD OF FORMING TWO-DIMENSIONAL OR THREE-DIMENSIONAL IMAGE, CURED MATTER, AND DECORATIVE OBJECT | RICOH COMPANY, LTD. (JP) | 2023-03-16 | — | — | US | disclosed |
| US-11529302-B2 | Composition, artificial nail composition, nail decoration material, artificial nail, stored container, image forming apparatus, and image forming method | RICOH COMPANY, LTD. (JP) | 2022-12-20 | — | — | US | disclosed |
| US-11529302-B2 | Composition, artificial nail composition, nail decoration material, artificial nail, stored container, image forming apparatus, and image forming method | RICOH COMPANY, LTD. (JP) | 2022-12-20 | — | — | US | disclosed |
| US-20200032089-A1 | COMPOSITION, CURED PRODUCT, STORAGE CONTAINER, IMAGE FORMING APPARATUS, AND IMAGE FORMING METHOD | RICOH COMPANY, LTD. (JP) | 2020-01-30 | — | — | US | disclosed |
| US-20200032068-A1 | COMPOSITION, CURED PRODUCT, STORAGE CONTAINER, IMAGE FORMING APPARATUS, AND IMAGE FORMING METHOD | RICOH COMPANY, LTD. (JP) | 2020-01-30 | — | — | US | disclosed |
| US-20200031969-A1 | COMPOSITION, CURED PRODUCT, STORAGE CONTAINER, IMAGE FORMING APPARATUS, AND IMAGE FORMING METHOD | RICOH COMPANY, LTD. (JP) | 2020-01-30 | — | — | US | disclosed |
| US-20190284409-A1 | COMPOSITION, CURED PRODUCT, COMPOSITION STORED CONTAINER, IMAGE FORMING APPARATUS, AND IMAGE FORMING METHOD | RICOH COMPANY, LTD. (JP) | 2019-09-19 | — | — | US | disclosed |
| CN-109280116-A | Constituent, solidfied material, image forming apparatus and image forming method | 株式会社理光 | 2019-01-29 | — | — | CN | disclosed |
| US-20190023924-A1 | COMPOSITION, CURED PRODUCT, IMAGE FORMING APPARATUS, AND IMAGE FORMING METHOD | RICOH COMPANY, LTD. (JP) | 2019-01-24 | — | — | US | disclosed |
| EP-3431557-A1 | COMPOSITION, CURED PRODUCT, IMAGE FORMING APPARATUS, AND IMAGE FORMING METHOD | Ricoh Company, Limited (JP) | 2019-01-23 | — | — | EP | disclosed |
| EP-3321333-A1 | CURABLE COMPOSITION, CURABLE INK, ACCOMMODATING CONTAINER, IMAGE FORMING DEVICE, IMAGE FORMING METHOD, CURED MATTER, AND ACRYLAMIDE COMPOUND | Ricoh Company Ltd. (JP) | 2018-05-16 | — | — | EP | disclosed |
| US-20180127607-A1 | CURABLE COMPOSITION, CURABLE INK, ACCOMMODATING CONTAINER, IMAGE FORMING DEVICE, IMAGE FORMING METHOD, CURED MATTER, AND ACRYLAMIDE COMPOUND | RICOH COMPANY, LTD. (JP) | 2018-05-10 | — | — | US | disclosed |
| US-20180127607-A1 | CURABLE COMPOSITION, CURABLE INK, ACCOMMODATING CONTAINER, IMAGE FORMING DEVICE, IMAGE FORMING METHOD, CURED MATTER, AND ACRYLAMIDE COMPOUND | RICOH COMPANY, LTD. (JP) | 2018-05-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180127607-A1 | CURABLE COMPOSITION, CURABLE INK, ACCOMMODATING CONTAINER, IMAGE FORMING DEVICE, IMAGE FORMING METHOD, CURED MATTER, AND ACRYLAMIDE COMPOUND | CRYAA, CDKN1A, ACR | CA12 1935/4885CA1 1090/4885CA2 1912/4885 |
| US-11529302-B2 | Composition, artificial nail composition, nail decoration material, artificial nail, stored container, image forming apparatus, and image forming method | NACA, PIK3C3, ACR | CA12 3466/4885CA1 3547/4885CA2 4412/4885 |
| US-12023398-B2 | Composition, artificial nail composition, nail decoration material, artificial nail, stored container, image forming apparatus, and image forming method | NACA, PIK3C3, POLR1C | CA12 3903/4885CA1 3191/4885CA2 4705/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.